Compremium
Compremium AG is a Swiss medical diagnostics company based in Bern, dedicated to transforming the diagnosis of pressure-related conditions in the human body through innovative, non-invasive platform technology. Their solutions are FDA cleared, used by NASA on the International Space Station, and are advancing pediatric and adult healthcare with a focus on pressure physiologies.
Industries
Nr. of Employees
small (1-50)
Compremium
Worbstrasse 46, 3074 Muri b. Bern, Switzerland
Patents
Pressure measurement device for measuring pressure and/or for measuring elasticity of a vein or an organ and for combination with an ultrasound measurement unit, pressure measurement system, and method
US-11957512-B2
View Details
Pressure measurement device for measuring pressure and/or for measuring elasticity of a vein or an organ and for combination with an ultrasound measurement unit, pressure measurement system, and method
US-11957512-B2
View DetailsProducts
Tissue compressibility monitoring system (lead device)
A bedside diagnostic system that quantifies relative tissue or muscle compressibility using ultrasound-coupled pressure sensing for real-time and intermittent monitoring to aid in diagnosis of compartment and pressure-related conditions.
Vessel pressure/occlusion pressure measurement prototype (investigational)
A non-invasive aid to measure vessel-related occlusion or venous pressures for applications in vascular and cardiac care; described as investigational for some indications.
Tissue compressibility monitoring system (lead device)
A bedside diagnostic system that quantifies relative tissue or muscle compressibility using ultrasound-coupled pressure sensing for real-time and intermittent monitoring to aid in diagnosis of compartment and pressure-related conditions.
Vessel pressure/occlusion pressure measurement prototype (investigational)
A non-invasive aid to measure vessel-related occlusion or venous pressures for applications in vascular and cardiac care; described as investigational for some indications.
Services
Partnerships with hospitals and investigators to run clinical studies, provide investigational devices for research use, and co-design study protocols.
Onboarding, training and demonstration services to enable clinical teams to integrate the measurement system into trauma, emergency and other point-of-care workflows.
Co-development and commercialization activities focused on pediatric applications, including clinical study facilitation and regulatory strategy for pediatric indications.
Partnerships with hospitals and investigators to run clinical studies, provide investigational devices for research use, and co-design study protocols.
Onboarding, training and demonstration services to enable clinical teams to integrate the measurement system into trauma, emergency and other point-of-care workflows.
Co-development and commercialization activities focused on pediatric applications, including clinical study facilitation and regulatory strategy for pediatric indications.
Expertise Areas
- Clinical trial design and execution
- Ultrasound-based diagnostic systems
- Medical device regulatory compliance (FDA 510(k), CE)
- Medical electronics and embedded system engineering
Key Technologies
- Ultrasound-based pressure measurement
- Tissue compressibility quantification
- Pressure sensing integrated with imaging
- AI-driven data analysis
News & Updates
Compremium is collaborating with Bern University Hospital to evaluate a new non-invasive diagnostic device for thyroid nodules, aiming to reduce unnecessary thyroid surgeries.
A strategic partnership to develop and commercialize non-invasive pressure monitoring technologies for pediatric care, focusing on congenital heart disease.
Awarded a $50,000 grant in the 'Make Your Medical Device Pitch for Kids!' competition for its non-invasive diagnostic device for children with heart conditions.
Compremium received FDA 510(k) clearance for its CPMX1 system, enabling real-time, non-invasive monitoring of muscle and tissue compressibility.
NASA commits to using CPMX1 for deep space missions to monitor astronaut health during long flights to Moon and Mars.
A clinical study at Inselspital Bern confirmed high reliability (ICC 0.911) of CPMX1 measurements in healthy volunteers.
Compremium is collaborating with Bern University Hospital to evaluate a new non-invasive diagnostic device for thyroid nodules, aiming to reduce unnecessary thyroid surgeries.
A strategic partnership to develop and commercialize non-invasive pressure monitoring technologies for pediatric care, focusing on congenital heart disease.
Awarded a $50,000 grant in the 'Make Your Medical Device Pitch for Kids!' competition for its non-invasive diagnostic device for children with heart conditions.
Compremium received FDA 510(k) clearance for its CPMX1 system, enabling real-time, non-invasive monitoring of muscle and tissue compressibility.
NASA commits to using CPMX1 for deep space missions to monitor astronaut health during long flights to Moon and Mars.
A clinical study at Inselspital Bern confirmed high reliability (ICC 0.911) of CPMX1 measurements in healthy volunteers.